Ironwood Pharmaceuticals, Inc. (IRWD)
4.43
+0.10
(+2.31%)
USD |
NASDAQ |
Apr 17, 16:00
4.43
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Research and Development Expense (Quarterly) : 21.40M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AbbVie, Inc. | 2.579B |
| Recursion Pharmaceuticals, Inc. | 83.34M |
| Cytokinetics, Inc. | 101.54M |
| Geron Corp. | 15.83M |
| Ionis Pharmaceuticals, Inc. | 279.36M |